News | Remote Monitoring | July 31, 2019

Eko Launches Eko Home Cardiac Remote Monitoring Application

Currently being used in a study by Mayo Clinic, Eko Home enhances outpatient cardiac data collection and demonstrates real world efficacy

Eko Launches Eko Home Cardiac Remote Monitoring Application

July 31, 2019 — Silicon Valley-based digital health company Eko announced Eko Home, a new service that enables precise remote monitoring of cardiac function using electrocardiogram (ECG) and heart sounds. Eko Home can be used to create drug-data combinations to demonstrate real-world efficacy for pharma trials, while simultaneously allowing clinicians to collect high-quality data while outside of the clinical environment.

The Eko Home application is currently being used in an active Mayo Clinic study. The purpose of the study is to evaluate different strategies of cardiovascular therapy with carvedilol, aiming to reduce the incidence of heart function declines and heart failure in at-risk breast cancer patients while on trastuzumab therapy.

The future of drug trials includes better data and continuous monitoring, according to a recent Harvard Business Review article. Per the authors, digital technologies “can revolutionize the antiquated process of developing new drug therapies and can vastly improve how we collect, measure and assess health data so that we can offer new treatments to patients without wasting valuable time and limited resources.” This is exactly what Eko Home offers to researchers, according to the company, providing precise monitoring for home cardiac patients using ECG and heart sounds, as well as other biometric data.

Eko expects to offer the drug-data combinations with other life science partners by the end of the year, with additional plans to offer its SDK to hospitals and healthcare providers that wish to build the platform directly into their applications.

For more information: www.ekohealth.com

Related Content

Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

Home October 29, 2021
Home
News | Cardiac Diagnostics

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used proprietary wearable cloth ...

Home October 04, 2021
Home
News | Cardiac Diagnostics

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

Home September 28, 2021
Home
News | Cardiac Diagnostics

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

Home July 29, 2021
Home
News | Cardiac Diagnostics

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
News | Cardiac Diagnostics

March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential ...

Home March 08, 2021
Home
News | Cardiac Diagnostics

March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...

Home March 03, 2021
Home
Subscribe Now